BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6339786)

  • 21. Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis.
    Szeto CC; Chow KM; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Jun; 22(6):1697-702. PubMed ID: 17259649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraperitoneal administration of insulin during peritoneal dialysis of diabetic patients with terminal renal failure.
    Andersen KE; Petersen PH
    Proc Eur Dial Transplant Assoc; 1981; 18():206-11. PubMed ID: 7036148
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of transperitoneal insulin transport.
    Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
    Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.
    Lahtela JT; Mustonen J; Pasternack A
    Clin Sci (Lond); 1995 Apr; 88(4):427-32. PubMed ID: 7789044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma insulin and glucose levels in diabetic patients undergoing continuous ambulatory peritoneal dialysis using insulin only in the dialysate.
    Dolgos ET; Vidt DG; Schumacher OP; Gupta MK
    Cleve Clin Q; 1984; 51(4):611-4. PubMed ID: 6395991
    [No Abstract]   [Full Text] [Related]  

  • 27. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
    Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients.
    Nevalainen P; Lahtela JT; Mustonen J; Pasternack A
    Nephrol Dial Transplant; 1997 Jan; 12(1):145-50. PubMed ID: 9027790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual function, blood pressure and blood glucose in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Rottembourg J; Bellio P; Maiga K; Remaoun M; Rousselie F; Legrain M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():330-4. PubMed ID: 3991520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intraperitoneal insulin therapy combined with continuous ambulatory peritoneal dialysis (CAPD)].
    Nevalainen P; Lahtela J; Mustonen J; Pasternack A
    Duodecim; 1996; 112(2):89-94. PubMed ID: 10590611
    [No Abstract]   [Full Text] [Related]  

  • 31. Administration of insulin by continuous ambulatory peritoneal dialysis.
    Chan E; Montgomery PA
    Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraperitoneal insulin during peritoneal dialysis for patients with diabetes and renal failure.
    Krothapalli R; Patel HS; Lacke C; Payne W; Knight TF; Senekjian HO; Weinman EJ
    South Med J; 1983 Apr; 76(4):512-4. PubMed ID: 6340216
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
    Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
    N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Permanent control of blood glucose in diabetic patients using continuous ambulatory peritoneal dialysis. Continuous insulin infusion by the intraperitoneal route].
    Martinand A; Belleville I; Cabanne JF; Chuet C; Morey W; Brun JM; Rifle G
    Presse Med; 1984 Jan; 13(3):165. PubMed ID: 6229747
    [No Abstract]   [Full Text] [Related]  

  • 35. An intraperitoneal insulin regimen for diabetics on continuous cyclic peritoneal dialysis.
    Aujla NS; Piraino B; Sorkin MI
    ASAIO Trans; 1990; 36(2):119-21. PubMed ID: 2187506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraperitoneal administration of insulin during peritoneal dialysis of diabetics with terminal renal failure.
    Anderson KE; Petersen PH
    Int J Artif Organs; 1981 Jul; 4(4):162-7. PubMed ID: 7035377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of peritoneal transport between insulin-dependent and noninsulin-dependent and noninsulin-dependent diabetic peritoneal dialysis patients.
    Lin JJ; Wadhwa NK; Suh H; Cabralda T
    Perit Dial Int; 1997; 17(2):208-9. PubMed ID: 9159849
    [No Abstract]   [Full Text] [Related]  

  • 38. Adsorption of insulin to the polyvinyl chloride surface of CAPD solution containers.
    Amidon G; Reichert JE; Johnson CA
    Proc Clin Dial Transplant Forum; 1980; 10():296-8. PubMed ID: 7050992
    [No Abstract]   [Full Text] [Related]  

  • 39. Dialysis considerations for diabetic patients.
    Khanna R
    Kidney Int Suppl; 1993 Feb; 40():S58-64. PubMed ID: 8445840
    [No Abstract]   [Full Text] [Related]  

  • 40. The peritoneal absorption of insulin in diabetic man: a potential site for a mechanical insulin delivery system.
    Schade DS; Eaton RP; Spencer W; Goldman R; Corbett WT
    Metabolism; 1979 Mar; 28(3):195-7. PubMed ID: 763154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.